Emma Hall
Papers
2
Total Citations
39
H-Index
2
About
Dr. Emma Hall is a leading clinical trialist whose work has fundamentally shaped the evidence base for prostate cancer treatment. Her primary research focus lies in the rigorous comparative effectiveness of radiotherapy and surgery, particularly through the landmark PACE (Prostate Advances in Comparative Evidence) study program. Dr. Hall’s most significant contribution is her leadership of the PACE-A trial, an international phase 3 randomised controlled trial that directly compared stereotactic body radiotherapy (SBRT) to surgery for localised prostate cancer. This work, published in 2023 with 31 citations, provides crucial randomised evidence in a field long dominated by observational data, addressing the critical question of whether SBRT offers improved quality of life over surgery. Her earlier work on patient acceptance of randomisation within the PACE study (8 citations) was foundational, demonstrating the feasibility of conducting such a challenging trial. By generating high-quality, randomised data on patient-reported outcomes, Dr. Hall has empowered clinicians and patients to make more informed, preference-sensitive decisions, cementing her reputation as a pivotal figure in uro-oncological clinical research.
Research Focus
Key Achievements
Top Papers
- 1
- 2